Below are some of the key investment decisions that our portfolio managers have made and the reasons for them.


IMP Monthly Report | May 2021

May was another strong month for the Australian share market with the ASX 200 Index posting a 1.93% gain for the period. This represents its 8th...

BYT | Carbon Revolution Limited

Founded in 2007, Carbon Revolution Ltd is a world recognised leader in the commercialisation and supply of lightweight carbon fibre wheels...

Webcentral Group Limited (ASX:WCG)

Webcentral Group’s (WCG) legacy and core business have survived the test of time. Founded in 1996, Melbourne IT (now WCG) had a strong presence in...

Cryptocurrency mania: what’s your edge?

Crypto is an increasingly dominant topic of conversation among investors, but is it a genuine asset class or the latest in a long list of financial manias?

BUY | Worley Limited

Worley Limited (WOR) is a leading global provider of professional project and asset services in the energy, chemicals, and resources sectors...

One to watch | Invex Therapeutics Limited

Invex Therapeutics Limited is in an enviable position, with ample working capital to see the company through the completion of phase 3 clinical trials...
Company Update

One to watch | Global Health Limited

Global Health’s services are deployed in over 1,000 healthcare organisations, supporting in excess of 1.5 million people. The company's solutions include...

IMP Monthly Report | April 2021

April delivered its best monthly performance in six months to see the S&P/ASX 200 rise by 3.5%, closing less than 2% below its pre-pandemic all-time highs..

BUY | Treasury Wine Estates Limited

Treasury Wine Estates has been hit hard by the COVID-19 pandemic-related shutdowns, with premium wine sales globally suffering amidst the closure of restaur

BUY | Qantas Airways Limited

Qantas is Australia’s dominant carrier and we see a number of drivers for Qantas over the next few years that can drive strong share price growth for...
Company Update

SUDA Pharmaceuticals Ltd: Potent drug delivery

Suda Pharmaceuticals Ltd (ASX:SUD) is one of the quiet achievers in the biotech sector that have, until recently, stayed off the radar of most investors...

IMP Monthly Report | March 2021

March was indeed another highly positive month for global markets including our own. Despite the pronounced rally in longer duration Government Bond...